As of December 29, 2022, clinicians are no longer required to obtain a DATA waiver (X-waiver) to prescribe buprenorphine to treat opioid use disorder. Visit the Substance Abuse and Mental Health Services Administration website for more information about the removal of the DATA waiver requirement.
The first in this series—Science to Medicine: Medication Treatment for Opioid Use Disorder (OUD)—offers quick, targeted information on how to get started offering OUD treatment medications and other recovery support services in your practice. Learn about the science behind it, hear how your peers have implemented it, find resources to get started, and propose a topic for the next Science to Medicine series.
Learn how clinicians in various practice settings have implemented medication treatment for opioid use disorder.
- Medication Treatment for Opioid Use Disorder in the Emergency Medicine Setting
- Medication Treatment for Opioid Use Disorder in the Federally Qualified Health Center Setting
- Medication Treatment for Opioid Use Disorder in the Inpatient Hospital Setting
- Medication Treatment for Opioid Use Disorder in the Pediatric (Adolescent Medicine) Setting
- Medication Treatment for Opioid Use Disorder in the Primary Care Setting
Propose New Topics/Contact Us
Have any questions about the content on this page or do you have another topic in mind for Science to Medicine? Contact NIDAMED Coordinator Brian Marquis with ideas or questions about Science to Medicine content.